BioEcho introduces EchoLUTION™ FFPE RNA Kit for superior RNA extraction from FFPE tissues

A leading provider of innovative molecular biology solutions, announces the launch of its EchoLUTION FFPE RNA Kit.

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis | Psychedelic Invest

Incannex Healthcare Inc. (Nasdaq: IXHL), (‘Incannex’ or the ‘Company’), a pharmaceutical company developing novel medicinal cannabinoid pharmacotherapies and psychedelic medicine therapies for unmet medical needs, is

January 24, 2024

People with disabilities hope autonomous vehicles deliver independence

Myrna Peterson predicts self-driving vehicles will be a ticket out of isolation and loneliness for people like her, who live outside big cities and have

December 12, 2023

Updated: Novartis close to acquiring Cytokinetics after biotech’s PhIII heart disease win — WSJ

Novartis is in discussions to buy Cytokinetics, the Wall Street Journal reported Monday, sending the biotech’s stock $CYTK soaring nearly 15%. The deal could be

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.